Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Your Environment. Your Health.

University of Washington

Superfund Research Program

Paraoxonase (PON-1): A Biomarker of Susceptibility to Environmentally-Induced Diseases

Project Leader: Lucio G. Costa
Grant Number: P42ES004696
Funding Period: 2000 - 2009

Project-Specific Links

Connect with the Grantees

Visit the grantee's eNewsletter page Visit the grantee's eNewsletter page Visit the grantee's Twitter page Visit the grantee's Facebook page Visit the grantee's Video page

Project Summary (2000-2006)

Paraoxonase (PON1) is an A-esterase that has been found to display a substrate-dependent polymorphism in humans. Determination of PON1 status (which includes both PON1192 genotype and level of expression) of an individual may allow the use of this enzyme as a biomarker of susceptibility to certain environmentally-induced diseases. The goal of this project is to carry out a series of experiments, the results of which will add important knowledge of PON1 function and modulation, thus increasing its reliability as a marker of susceptibility by better defining variables that affect its use in large epidemiological studies. Because PON1 detoxifies a number of organophosphates and metabolizes bioactive oxidized lipids, studies on PON1 have a direct impact on the susceptibility to pesticide poisoning and to cardiovascular diseases, particularly atherosclerosis. Furthermore, the emerging role of PON1 as an "antioxidant" protein may have importance in certain neuro-degenerative diseases such as Parkinson's disease. Several epidemiological studies have suggested that exposure to pesticides may be a risk factor for Parkinson's disease, and a recent study suggests that the PON1Q192 genotype may also be a risk factor for this disease. Project investigators are confirming and expanding this preliminary observation by determining PON1 status in groups of control and Parkinson's disease patients.

Back
to Top